MicroPort NeuroScientific (HKSE:02172) EBIT per Share: HK$0.45 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02172 MicroPort NeuroScientific Corp HKSE:02172
93 GF Score
Price HK$8.57
GF Value HK$13.97
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is MicroPort NeuroScientific EBIT per Share?

MicroPort NeuroScientific HKSE:02172 +1.00% 93 EBIT per Share is HK$0.45 as of Dec. 2025. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 681 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 72.25% on this metric.

MicroPort NeuroScientific's EBIT per Share for the six months ended in Dec. 2025 was HK$0.23. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.45.

During the past 12 months, the average EBIT per Share Growth Rate of MicroPort NeuroScientific was 7.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 27.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 40.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for MicroPort NeuroScientific's EBIT per Share or its related term are showing as below:

HKSE:02172' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 27.3   Med: 40.9   Max: 50.1
Current: 27.3

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of MicroPort NeuroScientific was 50.10% per year. The lowest was 27.30% per year. And the median was 40.90% per year.

HKSE:02172's 3-Year EBIT Growth Rate is ranked better than
72.25% of 681 companies
in the Medical Devices & Instruments industry
Industry Median: 9.4 vs HKSE:02172: 27.30

MicroPort NeuroScientific's EBIT for the six months ended in Dec. 2025 was HK$130.2 Mil.


MicroPort NeuroScientific  (HKSE:02172) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


MicroPort NeuroScientific EBIT per Share Related Terms


MicroPort NeuroScientific EBIT per Share Historical Data

* Premium members only.

The historical data trend for MicroPort NeuroScientific's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort NeuroScientific EBIT per Share Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial 0.16 0.21 0.31 0.56 0.45

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.32 0.25 0.22 0.23
HKSE:02172
93GF Score
MicroPort NeuroScientific Corp HKSE:02172
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MicroPort NeuroScientific EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

MicroPort NeuroScientific's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=256.472/570.549
=0.45

MicroPort NeuroScientific's EBIT per Share for the quarter that ended in Dec. 2025 is calculated as

EBIT per Share(Q: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=130.197/563.488
=0.23

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of HK$0.45 mean?
MicroPort NeuroScientific (HKSE:02172) has a EBIT per Share of HK$0.45 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MicroPort NeuroScientific and its competitors. According to the industry distribution chart, MicroPort NeuroScientific ranks #189 out of 681 companies in the Medical Devices & Instruments industry, placing it in the top 27.8%.
Is MicroPort NeuroScientific's EBIT per Share too high?
MicroPort NeuroScientific's current EBIT per Share is HK$0.45. Based on the distribution chart, MicroPort NeuroScientific ranks #189 out of 681 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #189 out of 681 companies for EBIT per Share. This puts MicroPort NeuroScientific in the upper half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MicroPort NeuroScientific and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort NeuroScientific's current EBIT per Share is HK$0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.97, compared to a current price of HK$8.57 — trading 38.7% below its estimated fair value. The current EBIT per Share is HK$0.45. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current EBIT per Share is HK$0.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued. The current stock price of HK$8.57 is trading 38.7% below its estimated GF Value™ of HK$13.97. GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.

Key valuation signals for HKSE:02172:

  • EBIT per Share: HK$0.45
  • GF Value™: HK$13.97 vs. price of HK$8.57 (38.7% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MicroPort NeuroScientific Business Description

Address No. 1661 Zhangdong Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score

Get the complete analysis for HKSE:02172

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$8.57
Price
HK$13.97
GF Value